-transparent.png){kind=logo}
Complement-fixing antibodies against an antigen prepared from the EB3 line of cultured Burkitt tumour cells were studied in various groups of patients and control individuals. Higher antibody titres were observed in patients with Burkitt's tumour than in African patients with other diagnoses. Significantly more medical students and nurses with a history of infectious mononucleosis possessed antibodies than those with no such history. Low levels of antibody were observed in patients during the acute phase of infectious mononucleosis and these levels were significantly lower than those in patients admitted to the same hospital with other diagnoses. During the early months following the acute phase of illness, EB complement-fixing antibodies remained stationary or apparently declined in titre but, in patients tested one or more years later, significantly higher antibody levels were observed.
R N Sutton, and
S D Marston, and
R T Emond
January 1966,
Acta medica Philippina,
R N Sutton, and
S D Marston, and
R T Emond
May 1950,
The Australian journal of experimental biology and medical science,
R N Sutton, and
S D Marston, and
R T Emond
April 1956,
Science (New York, N.Y.),
R N Sutton, and
S D Marston, and
R T Emond
February 1978,
The American review of respiratory disease,
R N Sutton, and
S D Marston, and
R T Emond
August 1978,
Archives of dermatology,
R N Sutton, and
S D Marston, and
R T Emond
June 1976,
Vestnik dermatologii i venerologii,
R N Sutton, and
S D Marston, and
R T Emond
September 1957,
Vox sanguinis,
R N Sutton, and
S D Marston, and
R T Emond
September 1981,
Archives of dermatology,
R N Sutton, and
S D Marston, and
R T Emond
December 1959,
Klinische Wochenschrift,
R N Sutton, and
S D Marston, and
R T Emond
July 1966,
Journal of immunology (Baltimore, Md. : 1950),
